The Beauty Health Company Statistics
Total Valuation
SKIN has a market cap or net worth of $177.49 million. The enterprise value is $394.38 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SKIN has 124.12 million shares outstanding. The number of shares has decreased by -6.82% in one year.
Current Share Class | 124.12M |
Shares Outstanding | 124.12M |
Shares Change (YoY) | -6.82% |
Shares Change (QoQ) | -12.59% |
Owned by Insiders (%) | 8.14% |
Owned by Institutions (%) | 59.02% |
Float | 80.65M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 14.05 |
PS Ratio | 0.54 |
Forward PS | 0.42 |
PB Ratio | 3.10 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.13 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.56, with a Debt / Equity ratio of 9.52.
Current Ratio | 6.56 |
Quick Ratio | 5.35 |
Debt / Equity | 9.52 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -6.98 |
Financial Efficiency
Return on equity (ROE) is -37.64% and return on invested capital (ROIC) is -6.72%.
Return on Equity (ROE) | -37.64% |
Return on Assets (ROA) | -5.90% |
Return on Capital (ROIC) | -6.72% |
Revenue Per Employee | $394,574 |
Profits Per Employee | -$31,976 |
Employee Count | 881 |
Asset Turnover | 0.42 |
Inventory Turnover | 2.32 |
Taxes
In the past 12 months, SKIN has paid $1.54 million in taxes.
Income Tax | 1.54M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.07% in the last 52 weeks. The beta is 0.91, so SKIN's price volatility has been similar to the market average.
Beta (5Y) | 0.91 |
52-Week Price Change | -34.07% |
50-Day Moving Average | 1.58 |
200-Day Moving Average | 2.35 |
Relative Strength Index (RSI) | 42.54 |
Average Volume (20 Days) | 1,033,048 |
Short Selling Information
The latest short interest is 8.51 million, so 6.86% of the outstanding shares have been sold short.
Short Interest | 8.51M |
Short Previous Month | 9.69M |
Short % of Shares Out | 6.86% |
Short % of Float | 10.55% |
Short Ratio (days to cover) | 10.46 |
Income Statement
In the last 12 months, SKIN had revenue of $347.62 million and -$28.17 million in losses. Loss per share was -$0.43.
Revenue | 347.62M |
Gross Profit | 175.64M |
Operating Income | -78.98M |
Pretax Income | -80.63M |
Net Income | -28.17M |
EBITDA | -41.88M |
EBIT | -78.98M |
Loss Per Share | -$0.43 |
Full Income Statement Balance Sheet
The company has $358.89 million in cash and $568.33 million in debt, giving a net cash position of -$209.44 million or -$1.69 per share.
Cash & Cash Equivalents | 358.89M |
Total Debt | 568.33M |
Net Cash | -209.44M |
Net Cash Per Share | -$1.69 |
Equity (Book Value) | 59.72M |
Book Value Per Share | 0.48 |
Working Capital | 411.10M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$5.51 million and capital expenditures -$710,000, giving a free cash flow of -$6.22 million.
Operating Cash Flow | -5.51M |
Capital Expenditures | -710,000 |
Free Cash Flow | -6.22M |
FCF Per Share | -$0.05 |
Full Cash Flow Statement Margins
Gross margin is 50.53%, with operating and profit margins of -22.72% and -8.10%.
Gross Margin | 50.53% |
Operating Margin | -22.72% |
Pretax Margin | -7.66% |
Profit Margin | -8.10% |
EBITDA Margin | -12.05% |
EBIT Margin | -22.72% |
FCF Margin | -1.85% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 6.82% |
Shareholder Yield | 6.82% |
Earnings Yield | -15.23% |
FCF Yield | -3.36% |
Analyst Forecast
The average price target for SKIN is $2.38, which is 66.43% higher than the current price. The consensus rating is "Hold".
Price Target | $2.38 |
Price Target Difference | 66.43% |
Analyst Consensus | Hold |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | 6.79% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SKIN has an Altman Z-Score of 0.18 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.18 |
Piotroski F-Score | 5 |